Florence Velge-Roussel

Professor Florence Velge-Roussel, has worked in immunology research on immune tolerance for 25 years and has been involved in many scientific projects and events, such as the International Meeting on Dendritic Cells (DC2014), which was held in Tours. Her current projects focus on developing therapeutic antibodies for inducing immune tolerance.

Ms Velge-Roussel has coordinated several collaborative projects, including a partnership with Danone Research from 2005 to 2012. She has been an active member of LabEx MabImprove (2012–2026) since the beginning of the PIA2 project (https://mabimprove.univ-tours.fr/fr/). Within this LabEx, she led the “Dendritic cell modulation” project, which involved one postdoctoral fellow and three PhD students and resulted in a patent in 2017. She was also the chair of the EU COST project BM1406 (2015–2019) (https://www.cost.eu/actions/BM1406/), which focused on 'ion channels and immune responses' and involved around 100 researchers from 26 countries. She also obtained a PERC project, DbA-Tol (2017–2021), from the French National Research Agency (ANR), in collaboration with the French start-up company McSaf, on bispecific drug conjugates. Finally, she was a WPL in a PIA3 project, BIO-S (2010–2022), with the pharmaceutical company Servier on antibody design and production. In 2022, she joined the CBM Institute's NMNS department to manage the 'Autologous Production of Antibodies' project with a PhD student.

In summary, she has experience of managing several national and international scientific projects.